-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Immunovant, Inc. quarterly/annual Depreciation history and growth rate from 2018 to Q2 2025.
- Immunovant, Inc. Depreciation for the quarter ending June 30, 2025 was $107K, a 33.8% increase year-over-year.
- Immunovant, Inc. annual Depreciation for 2024 was $377K, a 63.2% increase from 2023.
- Immunovant, Inc. annual Depreciation for 2023 was $231K, a 19.7% increase from 2022.
- Immunovant, Inc. annual Depreciation for 2022 was $193K, a 53.2% increase from 2021.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)